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Disinfection of drinking water is one of the
most important public health accomplish-
ments helping to dramatically reduce the
incidence of enteric diseases such as cholera
and typhoid (1). Although the effectiveness
in combating infectious agents is undisputed,
there has been concern over the production
of disinfection by-products (DBPs) during
water treatment and transport. Disinfection
by-products are formed when organic and
inorganic matter combines with oxidative
disinfectants. Toxicologic and epidemiologic
studies have reported that DBPs are associ-
ated with a variety of health effects.
The volatile DBPs (e.g., trihalomethanes)
have been heavily scrutinized since chloro-
form (the most prevalent trihalomethane) was
first reported to be a rodent carcinogen in
1976 (2). Other DBPs reported to be carcino-
genic in animal studies include the haloacetic
acids (3), haloacetonitriles (4), bromate (5),
and 3-chloro-4-(dichloromethyl)-5-hydroxy-
2(5H)-furanone (MX) (6). Toxicologic data
have indicated that the brominated tri-
halomethanes (such as bromoform and bro-
modichloromethane) are more carcinogenic
(7,8) and mutagenic (9,10) than chloroform.
Most of the genotoxicity detected in
chlorinated drinking water has been attrib-
uted to by-products in the nonvolatile frac-
tion (11). The haloacetic acids are the most
prevalent nonvolatile compounds (12), but
they have been shown to be weak mutagens
(13–15). MX has been shown to be one of
the most potent bacterial mutagens tested
(16). In addition to bacterial assays, MX is a
direct-acting mutagen and genotoxin in vivo
(17–21) and in mammalian cells in vitro
(21–27). MX is a multisite carcinogen in
male and female rats (6), with an estimated
cancer potency 170 times greater than chlo-
roform and 17 times greater than bro-
modichloromethane (28).
There is some inconsistency between the
toxicologic and epidemiologic data with
respect to organ speciﬁcity. The toxicologic
evidence indicates that the liver and kidney
are the primary target organs for DBPs (29).
The epidemiologic data suggests that tri-
halomethanes may be associated with cancer
of the bladder and rectum (30). Toxicologic
research typically focuses on the impact of
individual compounds, whereas epidemio-
logic studies evaluate mixtures of com-
pounds present in drinking water. Most of
the earlier epidemiologic work has focused
on total trihalomethane (TTHM) as a surro-
gate for total DBP exposure since it is rou-
tinely monitored. Although trihalomethanes
are typically the most prevalent class of
DBPs, they may not be an adequate marker
of exposure to individual compounds or of
exposure to the mixture of compounds.
Although no associations were reported
for bladder or rectal cancer, epidemiologic
research from Finland suggests that past
exposure to mutagenic substances in drinking
water may be associated with other types of
cancers (31–34). These data suggest that the
carcinogenic effects may be due to mutagenic
nonvolatile compounds, such as MX. High
MX concentrations (up to 67 ng/L) have
been reported in Finnish water systems (35).
MX was highly correlated with mutagenicity
in these samples, accounting for 15–57% of
the mutagenic activity in Ames tester strain
TA100. MX concentrations range from 3 to
9 ng/L in Japan (36) and from nondetectable
to 33 ng/L in the United Kingdom (37).
There are limited data on the occurrence of
MX and mutagenic activity in U.S. drinking
water supplies. Meier et al. (16) reported MX
concentrations of 2–33 ng/L in three loca-
tions, with MX accounting for 15–34% of
the mutagenic activity.
Disinfection by-product formation is
dependent on a variety of water quality para-
meters, including total organic carbon
(TOC), pH, temperature, contact time, disin-
fectant dose, and residual (38). TOC, ammo-
nia, and chlorine dose have been shown to be
influential in the production of mutagenic
activity (39). The choice of disinfectant
greatly inﬂuences the type and amount of by-
products that are formed. Chloramination
(40), ozonation (41), and a combination of
the two (39,42) have been shown to result in
reduced mutagenic activity. Alternative disin-
fectants result in fewer trihalomethanes (43)
but produce additional by-products. For
example, while ozonation is effective in limit-
ing trihalomethane formation, it produces
distinct DBPs (e.g. bromate) for which the
health effects are not well understood.
Type and quality of source water are also
critical to DBP formation. Due to the pres-
ence of natural organic matter, surface water
typically produces higher levels of DBPs
compared to groundwater. This is an impor-
tant issue in the United States because sur-
face water was the primary source for 61%
of the population served by public water sys-
tems in 1997 (44). Seventy-four percent of
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There is limited information on the prevalence of the potent mutagen 3-chloro-4-(dichloromethyl)-
5-hydroxy-2(5H)-furanone (MX) in U.S. water supplies. We measured MX concentrations and
mutagenic activity in tap water samples from 36 surface water systems throughout Massachusetts.
We found MX levels much higher (up to 80 ng/L) than previously reported in the United States.
We also evaluated the role of water treatment on mutagenic activity and disinfection by-product
formation. After adjusting for other covariates, chloramination and filtration were the most
important treatment options for reducing mutagenic activity and disinfection by-product forma-
tion. Multiple chlorine application (before and after filtration) was associated with increased
mutagenicity. Chlorine dose, pH, and total organic carbon were also associated with mutagenic-
ity, MX, and total trihalomethane (TTHM) concentration. Seasonal variation was evident for
MX and mutagenic activity, with higher levels occurring in the spring compared to the fall. In
contrast, TTHM concentrations were greater in the fall. Key words: disinfection by-products,
drinking water, mutagenicity, MX, trihalomethanes. Environ Health Perspect 110:157–164
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http://ehpnet1.niehs.nih.gov/docs/2002/110p157-164wright/abstract.htmlthe population served by community public
water systems in Massachusetts relies on sur-
face water or a combination of surface and
groundwater (45). With such a large exposed
population, characterizing the presence and
the health impact of DBPs is important.
We initiated this survey to measure muta-
genic activity and MX concentrations in
Massachusetts drinking water. An additional
objective was to gain a better understanding
of the factors that inﬂuence the formation of
MX and mutagenic compounds.
Methods
Sampling strategy. Tap water samples were
collected from 36 towns in Massachusetts
during 1997 and 1998. A geographically
diverse sample of surface water systems was
selected from towns with populations
> 10,000. Fourteen of the 36 towns (11 in
eastern Massachusetts and 3 in western
Massachusetts) are supplied by a single
source. The remaining 22 communities have
independent water supplies. One town with
its own surface water sources temporarily
switched over to the common uniﬁed source
in the summer of 1998. 
Water utilities in Massachusetts employ a
variety of disinfection strategies depending on
the size of the system and the quality of the
source water. Twenty-four of the sampled
towns use chlorine as their primary disinfec-
tant with 10 towns chlorinating their water
twice (i.e., before and after ﬁltration) prior to
distribution. One town used ozone and
another used chlorine dioxide as their primary
disinfectants (i.e., prior to filtration) while
relying on postﬁltration chlorination to main-
tain an adequate residual in their distribution
systems. The 12 remaining communities
used chloramination, with two towns from
the unified source beginning in September
1997. Another town that had historically
rechlorinated its water (following the initial
chlorination by the unified supplier) elimi-
nated this practice in August 1997. 
Tap water samples were collected from
30 towns in spring 1997. Four locations
were resampled in fall 1997 along with ﬁve
new sites, which were added to monitor the
effect of changes in chlorination practice.
Resampling occurred at 22 locations during
spring 1998 and 23 towns during fall 1998.
Fifteen communities had samples taken dur-
ing spring 1997, spring 1998, and fall 1998.
The 1997 samples were collected at regular
trihalomethane sampling sites or centrally
located sites in the distribution system. Most
of the 1998 samples were collected simultane-
ously by the water utilities in conjunction with
their quarterly trihalomethane monitoring.
The water departments provided data on
water quality characteristics thought to inﬂu-
ence the formation of DBPs (temperature,
pH, chlorine dose, chlorine residual, and
turbidity). We requested data for the loca-
tion and time closest to our samples. The
water departments also provided informa-
tion on their disinfection and ﬁltration prac-
tices. The unified water system in eastern
Massachusetts provided additional data on a
summary measure of five haloacetic acids
(HAA5) for 15 communities during 1997
and 1998. TOC measurements from
1997–2000 were available for most commu-
nities as part of the “Information Collection
Rule” (46). We categorized the TOC mea-
surements into low, intermediate, and high
levels.
Analytical protocol. Duplicate tap water
samples (n = 3) and control blanks (n = 5)
were collected for quality control purposes.
At each location, water was allowed to run
for several minutes to ﬂush out the impurities
and stabilize the temperature. A 4-L water
sample was then collected in a pre-cleaned
“Superfund grade” amber glass bottle with a
Teflon cap. The samples were extracted at
the Harvard School of Public Health
Exposure Assessment Laboratories. Samples
were allowed to sit for 2–5 days until they
were free of chlorine. Hydrochloric acid was
added to adjust the pH to 2 and stabilize the
MX. Organic materials were adsorbed via a
column of XAD-8 resin (Alltech Associates
Inc., Deerﬁeld, IL) at a ﬂow rate of approxi-
mately 35 mL/min. MX is fully recovered by
XAD-8 resin adsorption. The adsorbed
organics were eluted with 300 mL ethyl
acetate. Each extract was evaporated to 1 mL
ethyl acetate.
The extracts were shipped to the
Laboratory of Chemistry, National Public
Health Institute, in Kuopio, Finland. The
concentrated extract was then divided into
two parts for the analyses of MX and muta-
genicity. An internal standard mucobromic
acid was added to the MX extract, corre-
sponding to 180 ng/L of the original water.
The ethyl acetate solution was then evapo-
rated to dryness. The resultant residues were
dissolved and methylated in 300 µL 2%
(v/v) H2SO4. The solution was heated to
70°C to accelerate the reaction. The mixture
was neutralized by addition of 600 µg/L 2%
aqueous NaHCO3 and extracted twice with
600 µL n-hexane. Upon completion of the
preparation, MX concentration was mea-
sured using gas chromatography/mass spec-
trometry (GC/MS) (37).
Mutagenicity, measured as the number of
net revertants per liter (rev/L), was assayed
according to the plate incorporation method
of Ames et al. (47). The Ames test was con-
ducted on Salmonella typhimurium tester
strain TA100, which has been shown to be
the most sensitive strain for detecting muta-
genicity caused by MX (22). Since MX is a
direct-acting mutagen capable of inducing
mutations without metabolic activation, S9
mix was not used for the Ames test. Addition
of S9 mix reduces the mutagenicity of MX
by 90% in TA100 assays (22). For the muta-
genicity tests, the XAD extracts were dis-
solved in dimethyl sulfoxide. Sodium azide
and dimethyl sulfoxide were used as positive
and negative controls, respectively. Tests
were done on ﬁve dose levels with two plates
per dose. A linear dose response was used as
the criterion for positive mutagenicity. The
activity was calculated in the linear propor-
tion of the dose–response curves.
The quarterly trihalomethane samples
were collected by the respective towns and
analyzed by Massachusetts- or U.S.
Environmental Protection Agency (EPA)-
certified laboratories. Trihalomethane con-
centrations were measured using GC or
GC/MS according to U.S. EPA methods
502.2 and 524.2 (48). Standard protocol
included collection of duplicate water sam-
ples in 40 mL sampling vials and addition
of ascorbic acid and hydrochloric acid
prior to refrigeration. The Massachusetts
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Table 1. Mutagenic activity and disinfection by-product concentration in Massachusetts drinking water.
No. Mean SD Range
Mutagenicity (rev/L)
Spring 1997 30 2,000 1,271 400–5,700
Fall 1997 10 750 273 450–1,250
Spring 1998 22 1,500 797 300–3,450
Fall 1998 26 1,100 438 350–1,950
Total 88 1,450 975 300–5,700
MX (ng/L)
Spring 1997 30 35.5 20.8 10.1–79.9
Fall 1997 10 12.1 4.1 6.2–18.3
Spring 1998 22 25.3 15.4 4.0–61.1
Fall 1998 26 26.0 11.2 11.7–51.2
Total 88 27.5 17.0 4.0–79.9
TTHM (µg/L)
Spring 1997 29 31.8 22.6 5.5–82.0
Fall 1997 8 35.0 16.3 14.9–67.8
Spring 1998 22 34.5 19.2 8.0–65.5
Fall 1998 24 54.3 22.9 7.9–88.1
Total 83 39.1 23.3 5.0–88.1Department of Environmental Protection
and the individual water departments pro-
vided the trihalomethane results.
Statistical analysis. STATA, version 6,
was used for the statistical analysis (Stata
Corporation, College Station, TX). Pearson
correlation coefficients were calculated to
determine the strength of the linear relations
between the DBP indicators. We used two-
sided unpaired t-tests, assuming unequal
variances to compare stratified mean DBP
and mutagenicity levels. We used multiple
linear regression to determine the predictors
of mutagenicity, and MX and TTHM con-
centrations. Statistical significance was
deﬁned as p ≤ 0.05. Contribution of MX to
mutagenicity was determined by multiplying
the measured concentration of MX with the
tested TA100 mutagenicity of pure MX.
Results
Distribution of mutagenic activity and
DBPs. MX was not detected and mutagenic-
ity did not exceed the limit of detection
(100 rev/L) in the control blanks. The dupli-
cate samples indicated that there was limited
variability in MX and mutagenicity measure-
ments; the standard deviation of the dupli-
cates was 4 ng/L for MX and 200 rev/L for
mutagenicity.
Eighty-eight samples were collected from
36 towns over the four sampling periods.
Average mutagenicity was 1,450 rev/L with a
maximum of 5,700 rev/L (Table 1). Figure 1
shows the distribution of mutagenicity and
MX and TTHM concentrations. Average
mutagenicity was lower in the fall (mean =
1,000 rev/L) compared to the spring (mean =
1,800 rev/L). The mean MX concentration
was 28 ng/L, with a maximum of 80 ng/L
(Table 1). The distribution of MX was
skewed as shown in Figure 1. Twenty-six
samples from 16 towns had MX concentra-
tions > 33 ng/L and three samples were > 67
ng/L. MX levels were higher in the spring
(mean = 31 ng/L) compared to the fall (mean
= 22 ng/L). Matching TTHM measurements
were available for 83 of the 88 samples. The
mean TTHM concentration was 39 µg/L,
with a maximum of 88 µg/L (Table 1).
Although the TTHM distribution was
skewed toward higher values, there was a sug-
gestion of a bimodal distribution across the
sampling periods (Figure 1). In particular,
the fall 1998 mean TTHM concentration
was considerably higher (54 µg/L) than the
earlier sampling periods (mean = 33 µg/L).
This increase was most likely due to a change
in chlorination practice by the major water
supplier of eastern Massachusetts in the sum-
mer of 1998.
Correlation between mutagenic activity
and DBP concentrations. Mutagenicity was
highly correlated with MX concentrations
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Figure 1. Mutagenicity, MX, and TTHM concentrations in Massachusetts drinking water.
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Figure 2. Mutagenicity versus MX concentration.
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10 20 30 40 50 60 70 80 90across all four sampling periods (r = 0.86;
Figure 2). The period-specific correlation
coefficients were 0.92 for spring 1997 (n =
30), 0.65 for fall 1997 (n = 10), 0.70 for
spring 1998 (n = 22) and 0.81 for fall 1998
(n = 26; Table 2). There was considerable
variation in the regression slopes of muta-
genicity versus MX between sampling peri-
ods. The increase in mutagenicity associated
with each 1-ng/L increase in MX concentra-
tion was most pronounced in spring 1997
and decreased over successive sampling peri-
ods. On average, MX accounted for 51% of
mutagenicity across the sampling periods,
49% in spring 1997, 44% in fall 1997 and
spring 1998, and 63% in fall 1998.
TTHM concentration was moderately
correlated (r = 0.35) with HAA5 (n = 350)
collected for 15 towns in 1997 and 1998
(data not shown). Similar relationships were
observed between TTHM and mutagenicity
(r = 0.37; Figure 3) and TTHM and MX (r =
0.44; Figure 4), although there was consider-
able variability across the four sampling peri-
ods (Table 2). Most of the spring and fall
1998 samples were collected simultaneously
with routine trihalomethane monitoring.
There was a weaker correlation between the
matched MX and TTHM measurements (r =
0.36) than the unmatched samples collected
during spring and fall 1997 (r = 0.63). A
weaker correlation was found for the matched
mutagenicity and TTHM samples (r = 0.14)
compared to the unmatched samples (r =
0.69). Overall, TTHM concentration was
predictive of MX and mutagenic activity, but
this was mainly driven by the spring 1997
and fall 1998 sampling periods (Table 2). 
Predictors of mutagenic activity and
DBP concentration. We stratiﬁed the muta-
genicity, MX, and TTHM concentration
levels by treatment plant characteristics
(Table 3). Overall, there were small, but not
statistically signiﬁcant, increases in mean lev-
els of mutagenicity, MX, and TTHM with
the use of filtration and aluminum sulfate
for coagulation. Towns using activated car-
bon had higher levels of mutagenic activity
[600 rev/L; 95% confidence interval (CI),
50–1,150]. Chloramination was associated
with decreased mutagenicity (–600 rev/L;
95% CI, –1,000 to –100) and MX concen-
tration (–10 ng/L; 95% CI, –18 to –2). The
application of chlorine before and after fil-
tration was associated with increased muta-
genicity (500 rev/L; 95% CI, 0–1,000) and
MX (8 ng/L; 95% CI, –1 to 16).
We trichotomized the water quality indi-
cators to determine their effect on mutagenic
activity and DBP formation (Table 4).
Chlorine dose was associated with muta-
genicity, MX, and TTHM, whereas residual
chlorine in the distribution system was not
associated with the DBP indicators. Higher
pH (p < 0.01) and turbidity (p = 0.01) were
associated with TTHM concentration but
not with MX or mutagenic activity. A linear
trend in TTHM concentration was detected
for increasing temperature (p < 0.01).
Inverse relationships were observed between
temperature and both mutagenicity and
MX, although the tests for trend were not
statistically significant. Linear trends with
increasing TOC levels were detected for
mutagenic activity and MX concentration.
We identified predictors of mutagenic-
ity, MX, and TTHM via univariate linear
regression models. The crude and adjusted
results are shown in Table 5. Chloramination,
chlorine dose, and a marker for season were
consistent predictors of mutagenicity, MX,
and TTHM and were included in the core
multivariate models. The other covariates
were included in the regression models to
determine if they had an independent effect
on mutagenic activity and DBP formation.
After adjusting for the other covariates,
seasonality had the largest impact on muta-
genic activity. A difference of 800 rev/L
(95% CI, –1,300 to –300) in mutagenic
activity was observed in fall samples com-
pared to spring samples. A similar effect was
Articles • Wright et al.
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Table 2. Univariate linear regression of mutagenic activity and disinfection by-product concentration.
No. Slope (SE) Intercept (SE) ra
Mutagenicity versus MX
Spring 1997 30 56.1 (4.6) –5 (188) 0.92
Fall 1997 10 43.4 (17.8) 206 (226) 0.65
Spring 1998 22 36.2 (8.3) 587 (243) 0.70
Fall 1998 26 31.9 (4.7) 272 (132) 0.81
Total 88 49.2 (3.2) 111 (102)  0.86
Mutagenicity versus TTHM
Spring 1997 29 44.8 (6.1) 547 (236) 0.77
Fall 1997 8 9.3 (6.2) 448 (237) 0.28
Spring 1998 22 13.0 (8.8) 1,053 (345) 0.40
Fall 1998 24 11.5 (3.4) 450 (197) 0.52
Total 83 15.5 (4.3) 857 (195) 0.44
MX versus TTHM
Spring 1997 29 0.7 (0.1) 13.4 (4.1) 0.82
Fall 1997 8 0.1 (0.1) 9.3 (3.5) 0.48
Spring 1998 22 0.3 (0.2) 14.2 (6.5) 0.31
Fall 1998 24 0.3 (0.1) 11.5 (5.3) 0.59
Total 83 0.3 (0.7) 14.9 (3.2)  0.37
aPearson correlation coefﬁcient.
Figure 3. Mutagenicity versus TTHM concentration.
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Figure 4. MX concentration versus TTHM concentration.
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nated systems (–800 rev/L; 95% CI, –1,450
to –200). Filtration was also inﬂuential, with
ﬁltered supplies resulting in less mutagenicity
than unﬁltered water (–650; 95% CI, –1,250
to –50). Communities with multiple chlorine
application (before and after filtration) had
higher levels of mutagenic activity (550;
95% CI, –50 to 1,100). Chlorine dose,
TOC, and pH were also associated with
increased mutagenicity.
Seasonal differences were observed in the
MX samples—higher concentrations were
found in spring (10 ng/L; 95% CI, 2–19)
compared to fall (Table 5). Communities that
used ﬁltration (–12 ng/L; 95% CI, –23 to –2)
and chloramination (–17 ng/L; 95% CI, –27
to –6) had signiﬁcantly lower MX levels com-
pared to other methods of treatment.
Chlorine dose, TOC, and pH were also asso-
ciated with increased MX concentrations.
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Table 3. Inﬂuence of water treatment practices on mutagenic activity and disinfection by-product concentration.
Mutagenicity (rev/L) MX (ng/L) TTHM (µg/L)
No. Mean SD No. Mean SD No. Mean SD
Total 84 1,500 987 84 27.7 17.3 82 39.3 23.4
Plant characteristics 
Filtration 
Yes 37 1,600 875 37 29.6 15.6 37 39.5 21.7
No 47 1,400 1,070 47 26.3 18.5 45  39.1 24.9
Difference 200 3.3 0.4
Aluminum sulfate
Yes 30 1,650 826 30 29.7 15.0 30 41.7 21.2
No 54 1,400 1,064 54 26.6 18.5 52 37.9 24.6
Difference 250 3.1 3.8
Activated carbon
Yes 18 1,950 1,005 18 33.4 17.1 18 40.9 18.5
No 66 1,350 953 66 26.2 17.1 64 38.8 24.7
Difference 600a 7.2 2.1
Chloramination
Yes 29 1,100 414 29 21.2 10.7 28 37.5 25.0
No 55 1,700 1,140 55 31.2 19.1 54 40.2 22.7
Difference –600a –10.0a –2.7
Multiple chlorine applicationb
Yes 19 1,900 1,010 19 33.5 16.4 19 38.0 20.1
No 65 1,400 955 65 26.0 17.3 63 39.6 24.4
Difference 500 7.5 –1.6
aStatistically signiﬁcant difference (p < 0.05). bChlorine applied before and after ﬁltration.
Table 4. Inﬂuence of water quality indicators on mutagenic activity and disinfection by-product concentration.
Mutagenicity (rev/L) MX (ng/L) TTHM (µg/L)
No. Mean SD No. Mean SD No. Mean SD
Total 84 1,500 987 84 27.7 17.3 82 39.3 23.4
Water quality indicators
Cl2 dose
0.55–1.52 mg/L  27 1,250 660 27 24.8 13.7 27 28.0 20.2
1.53–1.95 mg/L 28 1,500 913 28 26.2 14.1 28 50.4 21.6
1.96–3.07 mg/L 26 1,850 1,260 26 34.4 21.9 25 40.4 23.8
Trend test p = 0.02 p = 0.02 p = 0.01
Cl2 residual
0.01–0.40 mg/L 25 1,250 822 25 24.5 15.2 24 34.9 25.1
0.41–0.87 mg/L 27 1,800 1,266 27 32.9 20.4 26 41.7 22.8
0.88–2.00 mg/L 27 1,500 804 27 27.8 16.0 27 39.2 23.8
Trend Test p = 0.68 p = 0.69 p = 0.47
pH
5.66–7.39 23 2,100 1,311 23 35.9 21.3 23 36.3 24.4
7.40–8.16 27 1,150 718 27 21.9 13.8 26 29.2 19.1
8.17–9.90 28 1,450 689 28 28.9 14.0 28 50.5 22.2
Trend test p = 0.09 p = 0.61 p = 0.002
Temperature
1.1–6.7 (°C) 28 1,950 1,276 28 34.6 21.4 27 38.7 25.2
6.8–11.0 (°C) 26 1,400 749 26 25.8 14.0 26 30.2 22.2
11.1–22.6 (°C) 26 1,250 690 26 25.1 13.6 26 49.0 19.5
Trend test p = 0.05 p = 0.12 p = 0.002
Turbidity
0.01–0.18 NTU 28 1,600  911 28 30.8 16.9 28 37.7 23.0
0.19–0.34 NTU 28 1,350 840 28 24.9 14.7 27 39.3 24.4
0.35–1.50 NTU  28 1,500 1,192 28 27.5 20.0 27 40.9 23.5
Trend test p = 0.66 p = 0.29 p = 0.01
TOC
2.0.–2.8 mg/L 36 1,150 628 36 21.2 11.7 35 39.4 22.5
2.9.–3.9 mg/L 19 1,350 761 19 27.2 15.6 19 29.1 19.4
4.0.–7.3 mg/L 20 2,000 1,271 20 36.3 19.5 20 50.0 23.2
Trend test p = 0.01 p = 0.01 p = 0.19
NTU, nephelometric turbidity unit.In contrast to MX and mutagenicity,
season was inversely associated with
TTHM levels, with higher values occurring
in the fall (–15 µg/L; 95% CI, –26 to –4).
Chloramination was associated with lower
TTHM concentrations (–15 µg/L; 95% CI,
–28 to –1). Other predictors of TTHM
concentration included TOC and pH.
Chlorine dose was marginally signiﬁcant (p
= 0.06) with every 1 mg/L increase in chlo-
rine resulting in an 8 µg/L (95% CI, 0–17)
increase in TTHM.
Temporal changes in DBPs and muta-
genic activity. Water samples were collected
for 15 communities in spring 1997, spring
1998, and fall 1998 to evaluate the role of
changes in treatment practices over time.
This analysis was restricted to 14 communi-
ties because one town changed its water
source during summer 1998. MX concen-
trations were higher in fall 1998 samples
than in spring samples in 1997 and 1998
(Table 6). TTHM levels were also higher
during fall 1998 compared to spring 1998.
Mutagenic activity was highest in spring
1997 but decreased during the next two
sampling periods.
MX and TTHM concentrations were rel-
atively stable over time when stratified by
water source, whereas mutagenicity decreased
in the towns with independent water sup-
plies. Mutagenicity, MX, and TTHM were
similar in spring 1997 and spring 1998 for
the seven eastern Massachusetts communi-
ties. This may have been due to the elimina-
tion of a rechlorination step in one of the
towns in January 1998. When the analysis
was restricted to the other six towns, TTHM,
MX, and mutagenicity all increased over the
three sampling periods. The temporal differ-
ences observed from spring to fall of 1998
within the uniﬁed eastern Massachusetts sys-
tem coincided with changes in disinfection.
The chlorine dose was increased as part of
the chloramination disinfection before spring
1998. Free chlorine was also added at an ear-
lier stage in the treatment process at one of
the main holding reservoirs, and the chlorine
contact time was increased before the addi-
tion of ammonia.
Discussion
MX concentrations in Massachusetts drink-
ing water were higher than previously
reported in the United States (maximum =
33 ng/L) (16) and in Finland (maximum =
67 ng/L) (35,49). Nearly one-third of the
Massachusetts drinking water samples were
> 33 ng/L and three samples were > 67 ng/L.
This suggests that high MX concentrations
are more prevalent in U.S. surface water sup-
plies than previously indicated.
Due to the multitude of mutagenic com-
pounds present in drinking water, it was use-
ful to obtain a direct measurement of
mutagenicity. We were interested in deter-
mining whether MX measurements provide
any additional information on potential
mutagenic activity and DBP levels beyond
that given by routine trihalomethane sam-
pling. In accordance with other ﬁndings, our
data indicated that MX concentrations were
highly correlated with mutagenic activity (r =
0.86). TTHM concentrations were not highly
correlated with mutagenic activity (r = 0.44)
for our samples collected during the fall and
spring months. Vartiainen et al. (39) reported
higher correlations in samples collected in
April (r = 0.63). This is in agreement with our
data, since we found the highest correlations
in samples collected exclusively in March
(spring 1997; Table 2). Nestmann et al. (50)
previously described seasonal variability in the
relationship between mutagenicity and chlo-
roform (higher correlation in summer vs.
winter). We also detected weaker correlations
between TTHM and HAA5 (r = 0.35) and
for TTHM and MX concentrations (r =
0.37). These findings have important epi-
demiologic implications because they suggest
that TTHM may not be a good surrogate for
nonvolatile DBPs or mutagenic activity.
Our findings indicate that mutagenic
activity is inﬂuenced by physical and chemi-
cal treatment of drinking water. Filtration
was associated with lower levels of MX after
adjusting for other water quality characteris-
tics and time of collection (Table 5). Similar
to previous reports, chloramination appeared
to limit the formation of TTHM, MX, and
mutagenic compounds. Chlorine dose and
total organic carbon were strong predictors
of mutagenicity and MX concentration.
These ﬁndings are in accordance with muta-
genic models developed by Vartiainen et al.
(39), who found that TOC, chlorine dose,
and to a lesser extent ammonia were impor-
tant predictors of mutagenic activity.
Trihalomethane formation has been
shown to be dependent on pH, with greater
concentrations occurring at higher pH (51).
In contrast, higher pH results in lower levels of
total organic halides. Previous work indicates
that the formation of MX and mutagenicity
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Table 5. Linear regression predictors of mutagenic activity and disinfection by-product concentration.
Mutagenicity (rev/L) MX (ng/L) TTHM (µg/L)
Univariate Multivariate Univariate Multivariate Univariate Multivariate
slope (SE) slope (SE) slope (SE) slope (SE) slope (SE) slope (SE)
Chloramination (yes vs. no) –535 (219)** –818 (306)# –10.0 (3.8)** –16.5 (5.3)# –2.7 (5.5) –14.5 (6.9)**
Filtration (yes vs. no) 171 (217) –662 (307)** 3.3 (3.8) –12.3 (5.4)** 0.4 (5.2) –9.6 (6.9)
Multiple chlorine applicationa (yes vs. no) 520 (252)** 529 (289)* 7.5 (4.5)* 7.2 (5.1) –1.6 (6.2) 3.6 (6.5)
Cl2 dose (mg/L) 375 (190)  522 (191)# 7.0 (3.3)** 7.6 (3.3)** 11.2 (4.5)** 8.4 (4.3)*
Cl2 residual (mg/L) 146 (246) 2.2 (4.3) 4.7 (5.8)
Turbidity (NTU) 168 (462) 8.0 (8.0) 27.4 (10.8)#
TOCb 411 (120)# 284 (142)** 7.5 (2.1)# 6.0 (2.5)** 4.2 (3.2) 8.8 (3.2)#
pH –226 (132) 465 (169)# –1.2 (2.3) 10.0 (2.9)# 9.6 (3.0)# 14.5 (3.8)##
Temperature (°C) –40.2 (20.1)** –0.6 (0.4) 1.5 (0.5)#
Season (spring vs. fall) 784 (195)## 809 (243)# 9.0 (3.6)** 10.4 (4.2)** –16.9 (4.9)# –15.3 (5.5)*
Year (1997 vs. 1998) 309 (206) 4.0 (3.6) –12.9 (5.2)**
aChlorine applied before and after ﬁltration. bCoefﬁcient explains the unit change from low-to-moderate or from moderate-to-high values.*p < 0.10. **p < 0.05. #p < 0.01. ##p < 0.001. 
Table 6. Mean (SD) mutagenic activity and disinfection by-product concentration in repeated samples for
seven eastern Massachusetts communities served by a single source and seven independent communities.
No. Spring 1997 Spring 1998 Fall 1998
Mutagenicity (rev/L)
Eastern Massachusetts  7 1,000 (531) 1,000 (131) 1,350 (370)
Independent 7 2,700 (1,558) 1,950 (1,037) 850 (458)
Total 14 1,850 (1,432) 1,500 (867) 1,100 (467)
MX (ng/L)
Eastern Massachusetts 7 20.0 (12.7) 17.0 (4.8) 37.9 (21.3)
Independent 7 48.7 (21.8) 32.7 (20.7) 41.6 (19.9)
Total 14 34.6 (22.7) 24.8 (16.6) 44.9 (20.1)
TTHM (µg/L)
Eastern Massachusetts 7 17.4 (11.8) 19.1 (6.7) 64.3 (8.3)
Independent 7 47.4 (23.3) 42.4 (16.4) 57.0 (25.1)
Total 14 32.4 (23.6) 30.8 (17.0) 60.7 (18.3)are also inversely associated with pH (52).
We observed a linear dependence of muta-
genicity and MX on pH, similar to TTHM
formation, after adjusting for other covari-
ates. Similar to other reports (39), we found
that other parameters are more inﬂuential in
the formation of MX and mutagenicity than
pH at levels typically found in distribution
systems (pH 6–10).
Seasonal variation (i.e., peaks in the
summer months) in trihalomethanes has
been widely reported, but information is
limited on the seasonality of nonvolatile
species and mutagenic activity. Mutagenicity
has been reported to be higher in spring due
to increases in temperature and runoff due
to rainfall (53) and slightly higher in winter
(compared to summer) (39). Our data indi-
cate that seasonal differences exist for both
MX and mutagenicity beyond that associ-
ated with increases in water temperature and
chlorine dosage (Table 5). Mutagenic levels
were higher in the spring (vs. the fall) in
repeated samples from seven independent
water systems in which no major chlorina-
tion changes occurred (Table 6). Because of
the changes in chlorination practices over
this period in the eastern Massachusetts
communities, we would not expect a similar
pattern. MX concentrations were similar
over time. Assumptions regarding seasonal
and spatial variability are built into many
exposure assessment constructs. Therefore,
additional data on the sources of variability
in mutagenic compounds would greatly
enhance epidemiologic efforts. 
The analysis of the water quality parame-
ters should be interpreted with caution
because the data provided by the water
departments cannot be independently veri-
fied. Data were not always available on the
sample collection dates, so we collected data
that were closest in time and location to our
samples. We were more interested in evalu-
ating the between-town variability, so lim-
ited daily within-town variability would have
minimal impact on our ﬁndings. The TOC
measurements were an exception because
data were not available at the time of sample
collection. Therefore, the data may not cor-
respond to levels of organics at the time of
our sampling. However, we assume that the
relative TOC rankings are valid and that
temporal variations would be similar across
towns within a given geographic region.
The U.S. EPA has recently established a
maximum contaminant level (MCL) of 60
µg/L for HAA5 and has revised the MCL to
80 µg/L for TTHMs (54). MCLs were also
established for bromate (10 µg/L) and chlo-
rite (1 mg/L). These standards are effective
December 2001 for public water systems
serving populations over 10,000 and
December 2003 for smaller systems. Other
DBPs are not currently regulated in the
United States, although the World Health
Organization has recommended that the for-
mation of MX be limited in drinking water
(55). We have demonstrated that MX and
mutagenic activity are found in significant
concentrations in Massachusetts surface
water and that TTHM may not be a good
surrogate for nonvolatile DBPs or mutagenic
activity. Although the impending regulations
are an important step in limiting exposure to
DBPs in drinking water, they are unlikely to
provide much information on the occur-
rence of mutagenic compounds.
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